ArticleFrontiers in microbiology2023
Whole-genome sequencing and phylogenetic analysis capture the emergence of a multi-drug resistant
Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 28 citations in OpenAlex.
- Salmonella Abortusequi-associated abortions in horses: Global epidemiology, diagnostic advances, prevention, antimicrobial resistance, and emerging control strategies.Veterinary world · 2026Review
- Molecular characterization of pESI-like megaplasmids inMicrobiology spectrum · 2026Article
- Assessing transcriptomic responses ofMicrobiology spectrum · 2026Article
- Weaknesses out of strength: PNA against the penicillin-binding proteins.Molecular therapy. Nucleic acids · 2026Article
- Article
- Genomic insights into the prevalence and genetic diversity ofFrontiers in microbiology · 2026Article
- Epidemiology and antimicrobial resistance ofInfectious diseases (London, England) · 2026Article
- High frequency of chromosomal polymyxin resistance in Escherichia coli isolated from dairy farm animals and genomic analysis of mcr-1-positive strain.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025Article
- Phenotypic and genotypic characterization of antimicrobial resistance and virulence profiles ofMicrobiology spectrum · 2025Article
- Biological and genomic characterization of a polyvalent phage PSH-1 against multidrug-resistant Salmonella Enteritidis.BMC microbiology · 2024Article
- Nationwide surveillance and characterization of the third-generation cephalosporin-resistantHeliyon · 2024Article
- Detecting Class 1 Integrons and Their Variable Regions inAntibiotics (Basel, Switzerland) · 2024Article
- Genomic characterization, in vitro, and preclinical evaluation of two microencapsulated lytic phages VB_ST_E15 and VB_ST_SPNIS2 against clinical multidrug-resistant Salmonella serovars.Annals of clinical microbiology and antimicrobials · 2024Article
- Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections.Antibiotics (Basel, Switzerland) · 2024Review
- Analysis of the hypovirulentMicrobiology spectrum · 2024Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: We analyzed the phenotypic and genotypic antimicrobial resistance, genomics and phylogeny of 200 Results: Of these, 33.5% were resistant to at least one antimicrobial and 19.5% were multi-drug resistant (MDR). Eleven isolates from different animal sources were phenotypically and genetically similar to the ESI clone. These isolates had a D87Y mutation in the Discussion: This dataset captured the emergence of the MDR ESI clone in multiple animal species and the first report of a pESI-like plasmid in isolates from horses in the U.S.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.